RxDoctor Payments Data

Jonathan Kessler, MD

Vascular & Interventional Radiology · Duarte, CANPI 1679786818

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $37,105 of the $43,784 with a category attached, or 84.7%. 21 manufacturers reported payments, led by Boston Scientific at 35.2% of the total. Reporting peaked in 2024 at $23,101 and has fallen 61.2% since, to $8,953 in 2025.

$43,784in general payments, 2019–2025

Across 78 payments — averaging $561.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$15K
  • Medical Device Business Services, Inc.$9K
  • Siemens Medical Solutions USA, Inc.$8K
  • Galvanize Therapeutics, Inc$5K
  • AstraZeneca$2K
  • Ethicon Endo-surgery Inc.$2K
  • plus $3K from 15 others
$26,751in research payments, 2019–2025

Across 5 payments — averaging $5350.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Angiodynamics, Inc.$25K
  • Philips North America LLC$2K

What the payments were for

  • Consulting fees$37,10585%
  • Travel & lodging$3,3758%
  • Food & beverage$3,3058%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,784 in reported general payments places this provider in the 85th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024
$228,787
Medicare patients
307
Services billed
1,857

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron14$139
Levofloxacin13$22

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Duarte

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →